相似文献
1
Evaluation of current strategies and future priorities for improving health in developing countries.
BMJ. 2005 Dec 17;331(7530):1457-61. doi: 10.1136/bmj.38658.675243.94. Epub 2005 Nov 10.
2
An analytical perspective of Global health initiatives in Tanzania and Zambia.
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4(Suppl 4):223. doi: 10.1186/s12913-016-1449-8.
3
Methods to assess the costs and health effects of interventions for improving health in developing countries.
BMJ. 2005 Nov 12;331(7525):1137-40. doi: 10.1136/bmj.331.7525.1137.
4
Maternal mortality in developing countries: challenges in scaling-up priority interventions.
Womens Health (Lond). 2010 Mar;6(2):311-27. doi: 10.2217/whe.10.8.
5
Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence.
Pediatrics. 2005 Feb;115(2 Suppl):519-617. doi: 10.1542/peds.2004-1441.
6
Evaluating health communication programs to enhance health care and health promotion.
J Health Commun. 2014 Dec;19(12):1449-59. doi: 10.1080/10810730.2014.954080.
7
WHO urges developing countries to invest in health.
Lancet. 2003 Nov 8;362(9395):1557. doi: 10.1016/S0140-6736(03)14784-8.
8
Building health promotion into health care reform in Russia.
J Health Adm Educ. 1996 Spring;14(2):265-78.
9
Economic evaluation of health promotion: friend or foe?
Aust N Z J Public Health. 1998 Apr;22(2):247-53. doi: 10.1111/j.1467-842x.1998.tb01182.x.
10
The role of health promotion in poverty reduction.
East Mediterr Health J. 2007 Nov-Dec;13(6):1249-55. doi: 10.26719/2007.13.6.1249.
引用本文的文献
1
The cost-effectiveness of sexual and reproductive health and rights interventions in low- and middle-income countries: a scoping review.
Sex Reprod Health Matters. 2021 Dec;29(1):1983107. doi: 10.1080/26410397.2021.1983107.
2
Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.
Adv Nutr. 2022 Feb 1;13(1):282-317. doi: 10.1093/advances/nmab097.
3
Priority Setting in HIV, Tuberculosis, and Malaria - New Cost-Effectiveness Results From WHO-CHOICE.
Int J Health Policy Manag. 2021 Nov 1;10(11):678-696. doi: 10.34172/ijhpm.2020.251.
4
Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.
PLoS One. 2017 Aug 24;12(8):e0183391. doi: 10.1371/journal.pone.0183391. eCollection 2017.
5
Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness.
PLoS One. 2017 Aug 10;12(8):e0182951. doi: 10.1371/journal.pone.0182951. eCollection 2017.
6
Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.
Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):140-61. doi: 10.1002/hec.3299.
7
Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland.
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2381-8. doi: 10.1007/s00405-015-3618-5. Epub 2015 Apr 2.
8
Reimbursement policies in the Asia-Pacific for chronic hepatitis B.
Hepatol Int. 2015 Jan;9(1):43-51. doi: 10.1007/s12072-014-9593-x. Epub 2014 Dec 11.
9
A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba.
PLoS One. 2015 Mar 13;10(3):e0121363. doi: 10.1371/journal.pone.0121363. eCollection 2015.
10
A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness").
PLoS Negl Trop Dis. 2015 Feb 5;9(2):e0003397. doi: 10.1371/journal.pntd.0003397. eCollection 2015 Feb.
本文引用的文献
1
Methods to assess the costs and health effects of interventions for improving health in developing countries.
BMJ. 2005 Nov 12;331(7525):1137-40. doi: 10.1136/bmj.331.7525.1137.
2
Time to reassess strategies for improving health in developing countries.
BMJ. 2005 Nov 12;331(7525):1133-6. doi: 10.1136/bmj.331.7525.1133.
3
Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
BMJ. 2005 Nov 12;331(7525):1107. doi: 10.1136/bmj.331.7525.1107.
4
Cost effectiveness analysis of strategies to combat malaria in developing countries.
BMJ. 2005 Dec 3;331(7528):1299. doi: 10.1136/bmj.38639.702384.AE. Epub 2005 Nov 10.
5
Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
BMJ. 2005 Dec 17;331(7530):1431-7. doi: 10.1136/bmj.38643.368692.68. Epub 2005 Nov 10.
6
Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
BMJ. 2005 Dec 10;331(7529):1364. doi: 10.1136/bmj.38645.660093.68. Epub 2005 Nov 10.
7
Cost effectiveness analysis of strategies for child health in developing countries.
BMJ. 2005 Nov 19;331(7526):1177. doi: 10.1136/bmj.38652.550278.7C. Epub 2005 Nov 10.
8
Limited good and limited vision: multidrug-resistant tuberculosis and global health policy.
Soc Sci Med. 2005 Aug;61(4):847-59. doi: 10.1016/j.socscimed.2004.08.046.
9
Programme costs in the economic evaluation of health interventions.
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1. doi: 10.1186/1478-7547-1-1.
10
Econometric estimation of country-specific hospital costs.
Cost Eff Resour Alloc. 2003 Feb 26;1(1):3. doi: 10.1186/1478-7547-1-3.
Zotero 插件